Table 4.
Comprehensive clinical efficacy of short, medium and long term treatment on blood glucose levels.
| Data periods | Before therapy (n) | Therapeutic effect base on blood glucose levels | |||
|---|---|---|---|---|---|
| Unchanged group (n) | Changed group (n, %) | X2 | p-Value | ||
| High blood glucose group | |||||
| Short term | 18 | 5 | 13 (72.22%) | 17.338 | <0.001 |
| Medium term | 7 | 3 | 4 (57.14%) | 3.150 | 0.076 |
| Long term | 2 | 0 | 2 (100%) | 1.000 | 0.317 |
| Normal blood glucose group | |||||
| Short term | 154 | 149 | 5(3.36%) | 3.253 | 0.071 |
| Medium term | 86 | 83 | 3 (4.65%) | 1.375 | 0.244 |
| Long term | 42 | 37 | 5 (13.51%) | 3.403 | 0.065 |
The definition of unchanged and changed of high blood glucose group were still high blood glucose group and changed to normal.
The definition of unchanged and changed of normal blood glucose were still normal and changed to high blood glucose group.